Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Biochemical material composition for preventing and treating disease caused by smooth muscle cell contraction in human organ

A technology of smooth muscle cells and biochemical substances, used in drug combinations, muscular system diseases, active ingredients of phosphorus compounds, etc., can solve the problems of patients with tinnitus that are not improved, and the cause and pathogenesis are not clear.

Inactive Publication Date: 2002-01-30
马赛厄斯·拉思
View PDF0 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The cause and pathogenesis of this disease are unclear and there is currently no effective therapy to improve the hearing of tinnitus sufferers

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Biochemical material composition for preventing and treating disease caused by smooth muscle cell contraction in human organ
  • Biochemical material composition for preventing and treating disease caused by smooth muscle cell contraction in human organ

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0024] Compositions of the following biochemical substances were administered to the patient in daily unit amounts of the substances indicated in this example:

[0025] biochemical substance

unit

quantity

ascorbic acid

mg

680

Ascorbyl palmitate

mg

620

β-, γ-, δ-tocopherol mixture

mg

22

β-carotene

I.U.

1665

Biotin

mcg

65

calcium ascorbate

mg

1050

Calcium Citrate

mg

200

calcium glycinate

mg

35

Carotenoid mixture (alpha-carotenoid

lutein, zea-, cryptoxanthin)

mcg

50

Cholecalciferol

I.U.

130

Chromium Glycinate

mcg

10

Citrus Bioflavonoids

mg

650

Coenzyme Q10

mg

7

Copper Glycinate

mcg

330

Cyanocobalamin

mcg

20

d-alpha-tocopherol

I.U.

230

Calcium d-pant...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to the use of biochemical substances for a composition for the prevention and treatment of health conditions caused by constriction of smooth muscle cells in organs of the human body like high blood pressure, asthma, glaucoma and tinnitus.

Description

technical field [0001] The present invention relates generally to the prevention and treatment of health-affecting diseases caused by the contraction of smooth muscle cells in human organs. Background of the invention [0002] The causes of many diseases are still unclear. The most common of these diseases of unknown origin include high blood pressure, asthma, glaucoma and tinnitus. For hypertension, one of the most famous textbooks in the field of medicine, "Harrison's Principles of Internal Medicine", describes that the cause of approximately 90% of patients is unclear. Worldwide, hundreds of millions of people suffer from these health-affecting diseases and the economic losses caused to society due to ineffective treatment of these health-affecting diseases are immeasurable. [0003] Worldwide, millions of people suffer from bronchial asthma (asthma). In its later stages, asthma is a debilitating disease leading to inability to work and social withdrawal. The cause of...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/015A61K31/047A61K31/122A61K31/195A61K31/198A61K31/205A61K31/355A61K31/375A61K31/4188A61K31/4415A61K31/455A61K31/51A61K31/525A61K31/592A61K31/714A61K33/06A61K33/14A61K33/24A61K33/32A61K33/42A61K36/75A61P9/00A61P9/12A61P11/00A61P11/06A61P27/00A61P27/06A61P27/16
CPCA61K33/14A61K31/375A61K31/195A61P1/00A61P1/06A61P11/00A61P11/06A61P13/00A61P15/00A61P21/02A61P27/00A61P27/06A61P27/16A61P43/00A61P9/00A61P9/12A61K2300/00A61K31/198A61K33/06
Inventor 马赛厄斯·拉思
Owner 马赛厄斯·拉思
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com